Elsevier

Title

AMP Homepage

The Journal of Molecular Diagnostics

 

 

 

 

 

 

 

 

 

 

Home / JMD /

Elsevier Journal Transition

AMP and ASIP Partner with Elsevier to Publish The Journal of Molecular Diagnostics

Authors' Frequently Asked Questions

Will the direction/scope of the JMD change?

How should I submit my manuscripts?

Will the editorial review process change?

Will author costs of publishing in the JMD change?

How will I review proofs of my accepted article?

How will my article be published?

Will the JMD continue to be compliant with PubMed Central deposit requirements?

Will the direction/scope of the JMD change?

The direction of the JMD will continue to be shaped by the Journal's Editors, publishing "high-quality, original papers on scientific advances in the translation and validation of molecular discoveries in medicine into the clinical diagnostic setting, and the description and application of technological advances in the field of molecular diagnostic medicine. The editors welcome for review articles that contain: novel discoveries or clinicopathologic correlations including studies in oncology, infectious diseases, inherited diseases, predisposition to disease, or the description or polymorphisms linked to disease states or normal variations; the application of diagnostic methodologies in clinical trials; or the development of new or improved molecular methods for diagnosis or monitoring of disease or disease predisposition."

How should I submit my manuscripts?

Authors should continue to submit new and revised manuscripts online at Rapid Review (https://www.rapidreview.com/ASIP2/CALogon.jsp). In an unrelated move, the online submission interface was updated in November to improve the author experience.

Will the editorial review process change?

The editorial decision-making process will remain with the Editor-in-Chief and Associate Editors. We will continue to seek expert review from experienced external reviewers to aid this process.

Will author costs of publishing in the JMD change?

Author costs of publishing will remain the same ($65/page, $550/color figure, $50/black and white figure, $50/table, $65/supplemental file). As always, any future changes in publication costs will be announced in advance and will appear in revised Instructions to Authors.

How will I review proofs of my accepted article?

Proofs will be provided by Elsevier via Cadmus Communications (Cenveo) via email for download, as in the past. You should follow the instructions therein for where to return your corrected pages.

How will my article be published?

The JMD (http://jmd.amjpathol.org) will remain online and in print form, at the same high quality you have come to expect.

Will the JMD continue to be compliant with PubMed Central deposit requirements?

The JMD will continue to deposit final published articles funded by NIH, HHMI, Wellcome Trust, and MRC in PubMed Central in compliance with each funding agency's requirements.